UC DIS.CERT. 09/24 HNR1/ DE000HD3ZMN6 /
27/06/2024 13:45:55 | Var.-0.030 | Denaro14:28:43 | Lettera14:28:43 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
233.550EUR | -0.01% | 233.870 Quantità in denaro: 2,000 |
233.890 Quantità in lettera: 2,000 |
HANNOVER RUECK SE NA... | - EUR | 27/09/2024 | Call |
GlobeNewswire
14:35
Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) For...
GlobeNewswire
14:35
Global Technologies, Ltd. Increases Shareholder Equity Through Preferred Stock Exchange
GlobeNewswire
14:30
ARB IOT Group Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
GlobeNewswire
14:30
Blue Star Foods Provides 2024 Revenue Guidance of At Least 65% Growth With Anticipated Annual Run-Ra...
GlobeNewswire
14:30
TSS Inc. (Total Site Solutions) Promotes Todd Marrott to Chief Operating Officer
GlobeNewswire
14:30
Comedian and Actor Drew “Druski” Desbordes Joins Safety Shot as Their Newest Brand Ambassador
GlobeNewswire
14:30
Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions
GlobeNewswire
14:30
Nasdaq Private Market Elects Industry Veteran Louis Citron As New Independent Board Member
GlobeNewswire
14:30
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global
GlobeNewswire
14:30
CytoDyn Announces Start of Preclinical MASH Study, Results Expected in Fall 2024
GlobeNewswire
14:30
Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting ...
GlobeNewswire
14:27
Aeroflow Health Launches Personalized Nutrition Services, Harnessing the Power of Food to Improve He...